Brevan Howard Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.2K Sell
232,369
-232,369
-50% -$214K ﹤0.01% 2025
2025
Q4
$1.05M Buy
+464,738
New +$748K 0.01% 743

Other funds holding GUTS

Brevan Howard Capital Management's GUTS Position: Q1 2026 in Review

Brevan Howard Capital Management reduced its Fractyl Health (GUTS) stake by 50% in Q1 2026, selling an estimated $214K and leaving 232,369 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Brevan Howard Capital Management first reported a position in GUTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.05M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Brevan Howard Capital Management held 232,369 shares of Fractyl Health worth $99.2K as of Q1 2026.
  • Brevan Howard Capital Management sold 232,369 Fractyl Health shares in Q1 2026, an estimated $214K.
  • Fractyl Health made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #2025 holding.
  • Brevan Howard Capital Management first reported a position in Fractyl Health in Q4 2025 and has held it in 2 quarters since.
  • Brevan Howard Capital Management's Fractyl Health position peaked at $1.05M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.